A quintessential setting for precision medicine, theranostics refers to a rapidly evolving field
of medicine in which disease is diagnosed followed by treatment of disease‐positive …

Structural imaging remains an essential component of diagnosis, staging and response
assessment in patients with cancer; however, as clinicians increasingly seek to …

The fundamental foundation for precision medicine is accurate and specific targeting of
cancer cells. Advances in the understanding of cancer biology, developments in diagnostic …

Highlights•The fundamentals of radiotheranostics, established therapies, and key clinical
studies.•Future developments: new targets, new radionuclides, new platforms, and …

Abstract'See what you treat and treat what you see, at a molecular level', could be the motto
of theranostics. The concept implies diagnosis (imaging) and treatment of cells (usually …

Molecular alterations in malignant disease result in the expression or upregulations of
various targets that can be used for imaging and treatment with radiopharmaceuticals. This …

Nuclear medicine is experiencing a renaissance, with US Food and Drug Administration
approval recently being obtained for theranostic agents and a wide variety of such agents …

Theranostic nuclear oncology is on the cusp of adoption into routine clinical management of
neuroendocrine tumours (NETs) following publication of the Phase 3 randomised controlled …

Introduction: Theranostics is an emerging field in which diagnosis and specific targeted
therapy are combined to achieve a personalized treatment approach to the patient. In …

Radiotheranostics with 177Lu-PSMA have changed the treatment paradigm in patients with
prostate cancer, becoming the new standard in certain settings. Terbium-161 (161Tb) has …